This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

AB1_RICKETTSIOSES

Other rickettsioses

EFO Endpoint Browser

AB1_OTHER_RICEKTTSIOSES

No definition available.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A79 Hospital discharge: ICD-9 — 08[2] Hospital discharge: ICD-8 — 08[2] Hospital discharge: excluded ICD-9 — 0820A Cause of death: ICD-10 — A79 Cause of death: ICD-9 — 08[2] Cause of death: ICD-8 — 08[2] Cause of death: excluded ICD-9 — 0820A 2 out of 7 registries used, show all original rules.	13
4. Check minimum number of events None	13
5. Include endpoints None	13
6. Filter based on genotype QC (FinnGen only)	13

Control definitions (FinnGen only)

Control exclude: AB1_RICKETTSIOSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_OTHER_RICEKTTSIOSES
CONTROL_EXCLUDE	AB1_RICKETTSIOSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A79
HD_ICD_9	08[2]
HD_ICD_8	08[2]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	0820A
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A79
COD_ICD_9	08[2]
COD_ICD_8	08[2]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	0820A
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other rickettsioses based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	122	51	70
Only index persons	109	45	64
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	52.70	58.76	47.91
Only index persons	50.87	56.04	47.24

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13	6	7
Unadjusted period prevalence (%)	0.00	0.00	0.00
Median age at first event (years)	48.33	44.35	51.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

7.58

2.85

1.4

1.6

—

(3023368) Bacteria identified in Blood by Culture

3.09

1.10

5.8

6.5

—

(3026008) Bacteria identified in Urine by Culture

2.96

1.07

2.2

3.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

104

+∞

0.90

6.3

5.0

38.3

38.7

mmol/mol

0.06

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

107

+∞

0.89

4.4

4.6

1.3

1.5

mmol/l

0.88

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

107

+∞

0.89

4.5

4.8

4.1

4.6

mmol/l

1.02

(3011397) Hemoglobin [Presence] in Urine by Test strip

2.26

0.75

4.6

5.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2.16

0.72

2.2

2.8

0.6

0.7

ug/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

110

+∞

0.67

5.2

5.1

2.3

2.7

mmol/l

0.70

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

109

+∞

0.67

4.3

4.7

6.4

5.9

mmol/l

0.68

103

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1.90

0.49

2.2

2.0

57.2

90.0

u/l

—

(3019225) pH of Specimen

0.00

0.44

0.0

6.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

0.44

0.0

3.4

—

32.3

—

(4035726)

0.00

0.44

0.0

1.4

—

(40768797) Stomach Pathology biopsy report

0.00

0.44

0.0

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.92

0.43

3.4

2.5

75.4

70.6

nmol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

0.43

0.0

10.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1.74

0.42

2.4

3.3

—

(42870588) Differential panel, method unspecified - Blood

1.63

0.28

7.6

7.8

—

(3015736) pH of Urine

1.61

0.26

5.5

4.2

—

(3044640) Blood type and Crossmatch panel - Blood

1.40

0.26

3.0

2.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1.40

0.26

7.4

3.5

—

(1761868) Lipid panel - Serum or Plasma

1.40

0.26

2.6

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1.46

0.25

4.3

4.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

120

+∞

0.22

15.1

12.3

25.2

23.9

u/l

0.14

114

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

0.00

0.22

0.0

3.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

117

+∞

0.22

28.8

20.6

79.9

80.0

umol/l

0.00

117

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.0

4.3

—

(4034850)

0.00

0.0

23.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1.10

0.00

6.8

4.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

0.00

0.0

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

78.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

0.00

0.0

5.1

—

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.00

0.0

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

40.0

—

(21494755) Public health laboratory ask at order entry panel

0.00

0.0

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

0.0

2.2

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1.07

0.00

7.1

5.4

9.4

10.5

mm/h

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1.13

0.00

23.2

8.7

1.2

mmol/l

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_OTHER_RICEKTTSIOSES and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_OTHER_RICEKTTSIOSES.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_RICEKTTSIOSES – Other rickettsioses

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other rickettsioses

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints